NCT03223376 2025-12-01
FRUTIGA
Hutchmed
Phase 3 Completed
Clinical Trials
3 trialsNCT02451956 2019-12-30
Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy
Samsung Medical Center
Phase 2 Completed
NCT01136031 2015-05-20
TI-2ndAGC
Seoul National University Hospital
Phase 1/2 Completed